Short answer
LifeMD, Inc. (LFMD) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $47M (down 24.0% year over year) with net income of −$7M.
Q2 2026 key financials · XBRL
- Revenue
- $47M
- −24.0% YoY · −5.7% QoQ
- Net income
- −$7M
- −241.4% YoY · +20.2% QoQ
- Operating margin
- -15.1%
- Gross margin
- 88.8%
- EPS (diluted)
- −$0.17
- −112.5% YoY · +15.0% QoQ
Source: XBRL data from the LifeMD, Inc. (LFMD) Q2 2026 10-Q on SEC EDGAR. USD.
LifeMD, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $47.3M, down 4% YoY from $49.0M, driven by $2.0M lower telehealth product revenue
- Gross margin 88.82% vs 86.05% YoY; gross profit $42.0M vs $42.2M
- Operating margin (15.08%) vs (4.79%) YoY; net loss $7.1M vs $1.1M
- Telehealth products worst performer, with revenue down approximately $2.0M on lower online sales demand
- Cost of telehealth revenue $5.3M, or 11% of revenue, vs $6.8M, or 14% YoY
Risk Factors
- No material changes to 2025 Form 10-K risk factors, filed March 10, 2026
- Credit risk: Credit Agreement waiver and first amendment dated June 30, 2026
- Regulatory risk: Rule 10b5-1 arrangement covering up to 65,000 shares beginning August 26, 2026
- Equity dilution risk: 50,000 shares issued for the OHHMD APA on May 13, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other LifeMD, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.